ORPHAN SYNERGY EUROPE-PHARMA (EPA:OSE) | WebDisclosure

Basculer en Français

9475	Companies
185456	Keywords
117803	Articles
99310	Press releases

Headlines Articles Press releases ORPHAN SYNERGY EUROPE-PHARMA

Home
Companies
ORPHAN SYNERGY EUROPE-PHARMA

PRESS RELEASE

published on 06/20/2025 at 19:30, 5 months 14 days ago

OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale dans la transparence, la sérénité des débats, et le respect des règles de marché
OSE Immunotherapeutics réaffirme son engagement à tenir une Assemblée Générale dans la transparence, la sérénité des débats et le respect des règles de marché. La société publie un document 'Questions-Réponses' pour informer ses actionnaires

Assemblée Générale Transparence OSE Immunotherapeutics Questions-Réponses Règles De Marché
PRESS RELEASE

published on 06/20/2025 at 19:30, 5 months 14 days ago

OSE Immunotherapeutics Reaffirms Commitment to Holding a Transparent and Serene General Meeting in Compliance with Market Rules
OSE Immunotherapeutics reaffirms commitment to transparent and serene General Meeting in compliance with market rules, providing 'Questions and Answers' document for shareholders

Shareholders Transparency General Meeting OSE Immunotherapeutics Market Rules
BRIEF

published on 06/19/2025 at 15:58, 5 months 15 days ago

Strategic change within OSE Immunotherapeutics

Board Of Directors General Meeting Crossing Thresholds OSE Immunotherapeutics Shareholders' Agreement
BRIEF

published on 06/19/2025 at 15:58, 5 months 15 days ago

Changement stratégique au sein d'OSE Immunotherapeutics

Assemblée Générale Conseil D'administration Franchissement De Seuils OSE Immunotherapeutics Pacte D'actionnaires
PRESS RELEASE

published on 06/19/2025 at 15:53, 5 months 15 days ago

Franchissement de seuils et déclaration d'intention
Déclaration de franchissement de seuils, déclaration d'intention et convention d'actionnaires de OSE Immunotherapeutics. Détails sur les actions et droits de vote

Franchissement De Seuils Action De Concert OSE Immunotherapeutics Déclaration D'intention Pacte D'actionnaires
BRIEF

published on 04/30/2025 at 07:35, 7 months 5 days ago

OSE Immunotherapeutics présente une nouvelle signature d'expression génique à l'AACR 2025

Immuno-oncologie Blocage Du Point De Contrôle Immunitaire Signature D'expression Génétique Traitement Personnalisé Prédiction Du Cancer
BRIEF

published on 04/30/2025 at 07:35, 7 months 5 days ago

OSE Immunotherapeutics Presents New Gene Expression Signature at AACR 2025

Immuno-oncology Personalized Treatment Immune Checkpoint Blockade Gene Expression Signature Cancer Prediction
PRESS RELEASE

published on 04/30/2025 at 07:30, 7 months 5 days ago

Immuno-Oncology Results from Research Collaboration with Léon Bérard Cancer Center Presented at AACR Annual Meeting 2025
OSE Immunotherapeutics and Léon Bérard Cancer Center present a new gene expression signature for predicting clinical response to immune checkpoint at AACR Annual Meeting 2025

AACR Annual Meeting OSE Immunotherapeutics Gene Expression Signature Léon Bérard Cancer Center Clinical Response Prediction
BRIEF

published on 04/09/2025 at 07:35, 7 months 26 days ago

OSE Immunotherapeutics présentera des données sur le lusvertikimab au DDW 2025

Rectocolite Hémorragique OSE Immunotherapeutics Lusvertikimab DDW 2025 Extension De La Phase 2
BRIEF

published on 04/09/2025 at 07:35, 7 months 26 days ago

OSE Immunotherapeutics to Present Data on Lusvertikimab at DDW 2025

Ulcerative Colitis OSE Immunotherapeutics Lusvertikimab Phase 2 Extension DDW 2025

Accesswire

Published on 12/05/2025 at 02:35, 11 hours 24 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 11 hours 29 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 12 hours 59 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 14 hours 54 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 14 hours 59 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 13:45, 13 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 59 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting
Published on 12/05/2025 at 13:00, 59 minutes ago

Form 8.3 - Zürcher Kantonalbank: Cicor Technologies Ltd.
Published on 12/05/2025 at 12:05, 1 hour 53 minutes ago

Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 1 hour 58 minutes ago

CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre

Les Echos

Published on 12/05/2025 at 08:45, 5 hours 14 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 5 hours 14 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 5 hours 16 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 19 hours 44 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 19 hours 59 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE